|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
0.83/1.92
|
Enterprise Value
22.85B
|
Balance Sheet |
Book Value Per Share
25.21
|
Cash Flow |
Cash Flow Yield
0.23
|
Income Statement |
Total Revenue
19.45B
|
Operating Revenue Per Share
35.11
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2024/06/01 10:04 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account forroughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line. |